MedPath

ADIENNE SA

ADIENNE SA logo
🇨🇭Switzerland
Ownership
Private
Established
2004-01-01
Employees
51
Market Cap
-
Website
http://www.adienne.com

Clinical Trials

9

Active:8
Completed:0

Trial Phases

2 Phases

Phase 1:7
Phase 3:1

Drug Approvals

8

CANADA:3
SFDA:2

Drug Approvals

TEPADINA

Approval Date
Nov 6, 2017
CANADA

TEPADINA

Approval Date
Oct 31, 2017
CANADA

TEPADINA

CANADA

Clinical Trials

Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials

Phase 1
7 (87.5%)
Phase 3
1 (12.5%)

Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD

Phase 3
Terminated
Conditions
Graft vs Host Disease
First Posted Date
2015-04-08
Last Posted Date
2020-01-30
Lead Sponsor
Adienne SA
Target Recruit Count
36
Registration Number
NCT02411084
Locations
🇺🇸

City of Hope Comprehensive Cancer Center, Duarte, California, United States

🇺🇸

University of Kansas Cancer Center and Medical Pavilion, Westwood, Kansas, United States

🇺🇸

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

and more 24 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.